WallStreetZenWallStreetZen

NASDAQ: TVGN
Tevogen Bio Holdings Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for TVGN

Based on 1 analyst offering 12 month price targets for Tevogen Bio Holdings Inc

Min Forecast
$100.00+1,645.2%
Avg Forecast
$100.00+1,645.2%
Max Forecast
$100.00+1,645.2%

Should I buy or sell TVGN stock?

Based on 1 analyst offering ratings for Tevogen Bio Holdings Inc.

Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their TVGN stock forecasts and price targets.

TVGN stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-03-03

1 of 1

Forecast return on equity

Is TVGN forecast to generate an efficient return?

Company
-799.49%
Industry
34.48%
Market
164.45%
TVGN's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is TVGN forecast to generate an efficient return on assets?

Company
1,502.08%
Industry
5.91%
TVGN is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

TVGN earnings per share forecast

What is TVGN's earnings per share in the next 3 years based on estimates from 3 analysts?

Avg 1 year Forecast
-$9.69
Avg 2 year Forecast
-$13.26
Avg 3 year Forecast
$15.81

TVGN revenue forecast

What is TVGN's revenue in the next 2 years based on estimates from 3 analysts?

Avg 1 year Forecast
$0.0
Avg 2 year Forecast
$1.4B

TVGN vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
TVGN$5.73$100.00+1,645.20%Strong Buy
SKYE$0.72N/AN/A
XCUR$3.78N/AN/A
SER$1.98N/AN/A
BRNS$0.57$4.00+604.23%Buy
View Top Biotech Stocks

Tevogen Bio Holdings Stock Forecast FAQ

Is Tevogen Bio Holdings Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: TVGN) stock is to Strong Buy TVGN stock.

Out of 1 analyst, 1 (100%) are recommending TVGN as a Strong Buy, 0 (0%) are recommending TVGN as a Buy, 0 (0%) are recommending TVGN as a Hold, 0 (0%) are recommending TVGN as a Sell, and 0 (0%) are recommending TVGN as a Strong Sell.

If you're new to stock investing, here's how to buy Tevogen Bio Holdings stock.

What is TVGN's earnings growth forecast for 2026-2028?

(NASDAQ: TVGN) Tevogen Bio Holdings's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 15.02%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 75.33%.

Tevogen Bio Holdings's earnings in 2026 is -$26,825,432.On average, 3 Wall Street analysts forecast TVGN's earnings for 2026 to be -$40,351,146, with the lowest TVGN earnings forecast at -$38,768,749, and the highest TVGN earnings forecast at -$41,537,945. On average, 3 Wall Street analysts forecast TVGN's earnings for 2027 to be -$55,217,358, with the lowest TVGN earnings forecast at -$53,051,972, and the highest TVGN earnings forecast at -$56,841,398.

In 2028, TVGN is forecast to generate $65,836,081 in earnings, with the lowest earnings forecast at $63,254,274 and the highest earnings forecast at $67,772,436.

What is TVGN's revenue growth forecast for 2027-2028?

(NASDAQ: TVGN) Tevogen Bio Holdings's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 54.79%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 16.86%.

Tevogen Bio Holdings's revenue in 2026 is $0.On average, 3 Wall Street analysts forecast TVGN's revenue for 2027 to be $0, with the lowest TVGN revenue forecast at $0, and the highest TVGN revenue forecast at $0.

In 2028, TVGN is forecast to generate $6,033,933,045 in revenue, with the lowest revenue forecast at $5,796,573,360 and the highest revenue forecast at $6,208,829,655.

What is TVGN's forecast return on assets (ROA) for 2026-2028?

(NASDAQ: TVGN) forecast ROA is 1,502.08%, which is higher than the forecast US Biotechnology industry average of 5.91%.

What is TVGN's Price Target?

According to 1 Wall Street analyst that have issued a 1 year TVGN price target, the average TVGN price target is $100.00, with the highest TVGN stock price forecast at $100.00 and the lowest TVGN stock price forecast at $100.00.

The Wall Street analyst predicted that Tevogen Bio Holdings's share price could reach $100.00 by Mar 3, 2027. The average Tevogen Bio Holdings stock price prediction forecasts a potential upside of 1,645.2% from the current TVGN share price of $5.73.

What is TVGN's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: TVGN) Tevogen Bio Holdings's current Earnings Per Share (EPS) is -$8.08. On average, analysts forecast that TVGN's EPS will be -$9.69 for 2026, with the lowest EPS forecast at -$9.31, and the highest EPS forecast at -$9.98. On average, analysts forecast that TVGN's EPS will be -$13.26 for 2027, with the lowest EPS forecast at -$12.74, and the highest EPS forecast at -$13.65. In 2028, TVGN's EPS is forecast to hit $15.81 (min: $15.19, max: $16.28).

What is TVGN's forecast return on equity (ROE) for 2026-2028?

(NASDAQ: TVGN) forecast ROE is -799.49%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.